A Prospective Study Comparing Injectable Interferon Beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) Injection Site Reaction in Multiple Sclerosis Patients
Electronic physician
doi 10.19082/7574
Full Text
Open PDFAbstract
Available in full text
Date
August 25, 2019
Authors
Publisher
Mehr Publishing Group